bpc-157 side effects safety human studies BPC-157: Miracle Healing Peptide or Hidden Danger? BPC-157: Experimental Peptide Creates Risk
Description
H., Bernal, F., Pitter, K
Using 1 mg twice weekly instead of 2.55 mg puts you below the level needed for angiogenesis
Weeks 9-16: optimization phase With both compounds at optimal doses, the body composition changes become significant
Ustekinumab (Stelara) What it treats: Plaque psoriasis and psoriatic arthritis How you take it: After the first shot, you get another 4 weeks later
